Abstract
Purpose
Liver diseases including non-alcoholic fatty liver disease (NAFLD) and ensuing alterations to the micro-environment may affect development of liver metastasis. Mirroring the rise in obesity rates, prevalence of NAFLD is increasing globally. Our objective was to examine the association between NAFLD and mortality in colorectal cancer patients.
Methods
Colorectal Cancer-Sarcopenia and Near-term Survival (C-SCANS) is a retrospective cohort study which included 3,262 stage I–III patients, aged 18–80 years, and diagnosed between 2006 and 2011 at Kaiser Permanente Northern California. Cox proportional hazards regression was used to calculate multivariable adjusted hazard ratios (HR) and 95% confidence intervals (CI).
Results
After up to 10 years of follow-up, 879 deaths, including 451 from CRC were identified. Cases diagnosed with NAFLD before and within 1 month after CRC diagnosis (pre-existing NAFLD; n = 83) had a HR of 1.64 (95% CI 1.06–2.54) for overall and a HR of 1.85 (95% CI 1.03–3.30) for CRC-specific mortality compared to those without NAFLD. Findings did not differ significantly by sex, stage, tumor location, and smoking status, and were also similar when restricted to obese patients only.
Conclusions
Independent of body mass index and prognostic indicators, CRC patients with pre-existing NAFLD had a worse prognosis than those without NAFLD.
Abbreviations
- BMI:
-
Body mass index
- CRC:
-
Colorectal cancer
- CI:
-
Confidence interval
- HR:
-
Hazard ratio
- KPNC:
-
Kaiser Permanente Northern California
- NAFLD:
-
Non-alcoholic fatty liver disease
References
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4):683–691
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A (2017) Colorectal cancer statistics. Cancer J Clin 67(3):177–193
Andre N, Schmiegel W (2005) Chemoradiotherapy for colorectal cancer. Gut 54(8):1194–1202
Lieber MM (1957) The rare occurrence of metastatic carcinoma in the cirrhotic liver. Am J Med Sci 233(2):145–152
Le MH, Devaki P, Ha NB, Jun DW, Te HS, Cheung RC, Nguyen MH (2017) Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLoS ONE 12(3):e0173499
Min YW, Yun HS, Chang WI, Kim JY, Kim YH, Son HJ, Kim JJ, Rhee JC, Chang DK (2012) Influence of non-alcoholic fatty liver disease on the prognosis in patients with colorectal cancer. Clin Res Hepatol Gastroenterol 36(1):78–83
You J, Huang S, Huang GQ, Zhu GQ, Ma RM, Liu WY, Shi KQ, Guo GL, Chen YP, Braddock M, Zheng MH (2015) Nonalcoholic fatty liver disease: a negative risk factor for colorectal cancer prognosis. Medicine 94(5):e479
Cai B, Liao K, Song XQ, Wei WY, Zhuang Y, Zhang S (2014) Patients with chronically diseased livers have lower incidence of colorectal liver metastases: a meta-analysis. PLoS ONE 9(9):e108618
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73–84
Rinella M, Charlton M (2016) The globalization of nonalcoholic fatty liver disease: prevalence and impact on world health. Hepatology 64(1):19–22
Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Dannenberg AJ, Kwan ML, Xiao J, Quesenberry C, Weltzien EK, Castillo AL, Caan BJ (2016) Metabolic dysfunction, obesity, and survival among patients with early-stage colorectal cancer. J Clin Oncol 30:3664
Meyerhardt JA, Kroenke CH, Prado CM, Kwan ML, Castillo A, Weltzien E, Cespedes Feliciano EM, Xiao J, Caan BJ (2017) Association of weight change after colorectal cancer diagnosis and outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomark Prev 26(1):30–37
Langley RR, Fidler IJ (2011) The seed and soil hypothesis revisited—the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer 128(11):2527–2535
Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343(8910):1405–1410
Murono K, Kitayama J, Tsuno NH, Nozawa H, Kawai K, Sunami E, Akahane M, Watanabe T (2013) Hepatic steatosis Is associated with lower incidence of liver metastasis from colorectal cancer. Int J Colorectal Dis 28(8):1065–1072
VanSaun MN, Lee IK, Washington MK, Matrisian L, Gorden DL (2009) High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. Am J Pathol 175(1):355–364
Funding
Grant from the National Cancer Institute R01CA175011 to Dr. Bette Caan is acknowledged.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wu, K., Zhai, M.Z., Weltzien, E.K. et al. Non-alcoholic fatty liver disease and colorectal cancer survival. Cancer Causes Control 30, 165–168 (2019). https://doi.org/10.1007/s10552-018-1095-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-018-1095-z